Medicare Part B premiums will not be reduced in 2022

AARP has asked CMS to lower this year’s premium. “It is irresponsible for a single outrageously expensive drug to be driving up premiums for all Medicare beneficiaries — many of whom are already struggling to make ends meet,” said Nancy LeaMond, executive vice president and chief advocacy and engagement officer from AARP, and requested a revaluation of the bounty of $170.10. “Now that the drugmaker has cut the price in half, the Medicare Part B premium hike should also be cut.”

CMS officials say that accounting for the savings in what Medicare is likely to have to spend on beneficiaries who are eligible for Aduhelm “when calculating the 2023 Medicare Part B premium is the most effective way to distribute those savings to people.” repay with Medicare Part B.” CMS is expected to announce the 2023 Part B award in the fall.

In their report, CMS officials say they determined that “a mid-year reassessment of the management fee is not operationally feasible” and that the agency never changed the mid-year fee. CMS advises that it would not be authorized to issue award refunds to all Part B participants. The report also states that without the impact of Aduhelm’s coverage, the monthly base premium for 2022 Part B would have been $160.30. The premium for 2021 Part B was $148.50.

Dena Bunis covers Medicare, Healthcare, Health Policy and Congress. She also writes the Medicare Made Easy column for the AARP Bulletin. An award-winning journalist, Bunis spent decades working for major city newspapers, including as head of the Washington bureau for the Orange County Registry and as a writer for Health Policy and the Workplace Newsday.

Comments are closed.